ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
| Project Title | Institution / Principal Investigator(s) | Grant Type | Year |
State |
|---|---|---|---|---|
| Synergistic Activity of Anti-GD2 Antibody and CD47-Blockade for Immunotherapy of Neuroblastoma and Osteosarcoma | The Board of Trustees of the Leland Stanford Junior University / Robbie Majzner, MD | 'A' Award Grants | 2019 | California |
| RAF Dimer Inhibitor Treatment in Pediatric Acute Myeloid Leukemia | The Regents of the University of California San Francisco / Kevin Shannon, MD | Innovation Grants | 2024 | California |
| Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma | Children’s Hospital Los Angeles / Robert Seeger, MD & Alan Wayne, MD | Innovation Grants | 2015 | California |
| Identifying Novel Therapeutic Combinations with 131I-MIBG to Treat Relapsed and Refractory Neuroblastoma | The Regents of the University of California San Francisco / William Clay Gustafson, M.D., Ph.D. | Reach Grants | 2014 | California |
| Targeting TGFb Pathway Dependencies in Group 3 Medulloblastoma | University of California San Francisco / Zulekha Qadeer, PhD | Young Investigator Grants | 2019 | California |
| Single Cell Analysis of Leukemia Initiation | Stanford University / Michael Cleary, MD | Innovation Grants | 2015 | California |
| Role of Fetal Growth in Pediatric Rhabdomyosarcoma | University of California Berkeley / Catherine Metayer, MD, PhD | Epidemiology Grants | 2013 | California |
| Characterization of Pre-Leukemia Associated with Familial RUNX1 Mutations | Stanford University / Ravi Majeti, MD/PhD | RARE Grant Program (Research Accelerating RUNX1 Exploration) | 2016 | California |
| Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma | Children’s Hospital Los Angeles / Shahab Asgharzadeh, MD | Innovation Grants | 2015 | California |
| GD2-directed CAR T cell therapy for H3K27M+ spinal cord diffuse midline glioma | Board of Trustees of the Leland Stanford Junior University / Michelle Monje | Catalyst Grants | 2021 | California |